Abstract
Cyclosporin A (CsA) is a potent immunosuppressant affecting many components of cellular and humoral immunity. Its main action probably results from inhibition of T-lymphocyte activation and interference with secretion of cytokines like IL-2, IL-4, IFN-gamma and TNF-alpha. Correspondingly, CsA has beneficial effects on the course of several autoimmune diseases thought to be mediated by T-lymphocytes, including a mild effect on multiple sclerosis. We exposed CD4 + cytotoxic T-lymphocytes specific for myelin basic protein, a putative target autoantigen in MS, to CsA in vitro, and determined the drug's effects on proliferation, expression of high affinity IL-2R, secretion of the proinflammatory cytokines IFN-gamma and TNF-alpha as well as on the secretion of the chemokines MIP-1 alpha and MIP-1 beta. In all instances, we observed a partial to complete inhibition. In contrast, the response of activated cells to IL-2 was resistant to CsA. Our observations are in line with results obtained in different experimental systems. The discrepancy between the profound inhibition of T-cells and the modest therapeutic effects on MS is discussed.
References
May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·D A FrumanS J Burakoff
Jan 1, 1992·Agents and Actions·C Bolton
Feb 1, 1990·Clinical and Experimental Immunology·N SuzukiT Tsunematsu
Nov 1, 1990·Neurology·M PetteH Wekerle
Jun 1, 1990·Annals of Neurology
Oct 1, 1990·Journal of Neurochemistry·D J BegleyJ Greenwood
Jan 1, 1989·Arthritis and Rheumatism·P GepnerC Fournier
Dec 22, 1989·Science·E A EmmelG R Crabtree
May 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·P RudgeT Poole
Aug 1, 1987·The Journal of Experimental Medicine·T EspevikM A Palladino
Jan 1, 1988·Annals of Neurology·L KapposU S Gugerli
Apr 1, 1987·The Journal of Clinical Investigation·A G PalestineR B Nussenblatt
Dec 21, 1984·Science·J F ElliottV Paetkau
Oct 9, 1980·Nature·T Paavonen, P Häyry
Nov 1, 1982·Journal of the Neurological Sciences·C BoltonA M Turner
Oct 1, 1995·Neurology·L A StoneH F McFarland
Sep 7, 1995·Annals of the New York Academy of Sciences·K A Smith
Jun 1, 1995·International Journal of Immunopharmacology·C Paul, C Bolton
Jan 1, 1994·Neurology·R MartinH F McFarland
Mar 1, 1994·Annals of Neurology·J P AntelJ McLaurin
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·V A BoussiotisA E Goldfeld
Apr 1, 1995·Immunity·J X LinS John
May 1, 1993·Trends in Pharmacological Sciences·J F Bach
Oct 1, 1993·The Journal of Experimental Medicine·A E GoldfeldA Rao
May 1, 1993·Annals of Neurology·M E SmithH F McFarland
Oct 15, 1995·Microscopy Research and Technique·M C Dal CantoS D Miller
Sep 1, 1995·Immunopharmacology·B RyffelG Woerly
Dec 1, 1995·Journal of Neuroimmunology·I ElovaaraS Jacobson
Apr 1, 1996·The Journal of Experimental Medicine·M T EsserV L Braciale
Jul 1, 1996·Brain Pathology·C F Brosnan, C S Raine
Jan 23, 1999·Journal of Neuroimmunology·K J KennedyW J Karpus
Jan 1, 1993·Ocular Immunology and Inflammation·F G RobergeM D De Smet